Larimar Therapeutics, Inc. Gains 31.32%
Tue, Feb 24, 2026 at 07:31 PM
Larimar Therapeutics, Inc. (LRMR:NASDAQ) jumped higher at $3.69, a gain of 31.3%. On Tue, Feb 24, 2026, LRMR:NASDAQ hit a New 2-Week High of $3.69. The stock appeared on our News Catalysts scanner on Tue, Feb 24, 2026 at 02:14 PM in the 'BIOTECH' category. From Tue, Feb 10, 2026, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Fri, Sep 26, 2025 at $5.37 with a volume of 3M+.
About Larimar Therapeutics, Inc. (LRMR:NASDAQ)
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Top 10 Gainers:
- Edesa Biotech, Inc. (EDSA:NASDAQ), 67.96%
- Rich Sparkle Holdings Limited (ANPA:NASDAQ), 52.93%
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 40.23%
- Clarivate Plc (CLVT:NYSE), 39.88%
- Ten-League International Holdings Limited (TLIH:NASDAQ), 37.74%
- Palvella Therapeutics, Inc. (PVLA:NASDAQ), 37.08%
- Founder Group Limited (FGL:NASDAQ), 34.26%
- Larimar Therapeutics, Inc. (LRMR:NASDAQ), 31.32%
- Gain Therapeutics, Inc. (GANX:NASDAQ), 31.1%
- Global Interactive Technologies, Inc. (GITS:NASDAQ), 30.9%